Title : Multidrug resistance protein 2 implicates anticancer drug-resistance to sorafenib.

Pub. Date : 2011

PMID : 21372398






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Multidrug resistance protein 2 implicates anticancer drug-resistance to sorafenib. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens
2 Inhibitory concentration of 50% cell growth of sorafenib significantly rose to 6.4-fold in a multidrug resistance protein 2 (MRP2) transfected cell line versus control cell line. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens
3 Inhibitory concentration of 50% cell growth of sorafenib significantly rose to 6.4-fold in a multidrug resistance protein 2 (MRP2) transfected cell line versus control cell line. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens
4 The present study suggest that sorafenib is a substrate for MRP2, suggesting that MRP2 may implicate drug resistance to sorafenib. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens
5 The present study suggest that sorafenib is a substrate for MRP2, suggesting that MRP2 may implicate drug resistance to sorafenib. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens
6 The present study suggest that sorafenib is a substrate for MRP2, suggesting that MRP2 may implicate drug resistance to sorafenib. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens
7 The present study suggest that sorafenib is a substrate for MRP2, suggesting that MRP2 may implicate drug resistance to sorafenib. Sorafenib ATP binding cassette subfamily C member 2 Homo sapiens